A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.

CompletedOBSERVATIONAL
Enrollment

1,022

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Healthy Condition
Interventions
DIAGNOSTIC_TEST

Medical examination or treatment.

Medical examination or treatment when delayed on-set nodule or other side effects occur due to Y-Solution filler injection.

Trial Locations (1)

Unknown

Dong Yeop Shin, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT04738019 - A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer. | Biotech Hunter | Biotech Hunter